38091210

https://pubmed.ncbi.nlm.nih.gov/38091210

A patient with lung adenocarcinoma developed seropositive neuromyelitis optica after treatment with the immune checkpoint inhibitor Atezolizumab.

Please note that this is an AI-generated summary and does not represent my views. For the actual PubMed abstract, please click on the provided PubMed link. This website aims to simplify and summarize PubMed abstracts, thereby disseminating scientific information from NCBI to the general public.